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Emergency physicians (EP) frequently encounter angioedema involving the lips and tongue. 
However, angioedema from Angiotensin Converting Enzyme inhibitors or hereditary angioedema 
(HAE) can present with gastrointestinal symptoms due to bowel wall involvement. EPs should begin 
to consider this clinical entity as a potential cause for abdominal pain and associated gastrointestinal 
symptoms given the common use of medications that can precipitate angioedema. We report a case 
of a 34-year-old woman who presented with abdominal cramping, vomiting and diarrhea due to an 
acute exacerbation of HAE. [West J Emerg Med. 2010; 11(4):391-394.]
INTRODUCTION
Intestinal angioedema is less commonly encountered by 
emergency physicians (EP) than angioedema of the lips and 
tongue and therefore may be unrecognized. Prompt detection 
and treatment of this rare disease can significantly improve 
patient outcome by minimizing morbidity from misdiagnosis 
or unnecessary operative interventions. EPs should be aware 
that hereditary angioedema (HAE) and medications, such as 
Angiotension Converting Enzyme (ACE) inhibitors, can cause 
intestinal angioedema and therefore may present with 
gastrointestinal complaints. In this case report, we will review 
the features that may help differentiate intestinal angioedema 
from other, more common, etiologies of abdominal pain with 
gastrointestinal symptoms. We also provide a review of the 
literature including therapy, which remains controversial in the 
emergency department (ED) setting. 
A review of emergency medicine (EM) literature revealed 
no previously reported cases of isolated intestinal angioedema 
caused by HAE. A few such cases have been described in 
radiology and gastroenterology literature spanning several 
decades.1-9 However, a case of ACE-inhibitor associated 
intestinal angioedema was recently described in the EM 
literature.10 
CASE REPORT
A 34-year-old African-American female who denied any 
prior medical history presented to the ED complaining of a 
three-day history of diffuse, constant abdominal “cramping” 
with associated nausea, vomiting and blood-streaked diarrhea. 
She received two liters of crystalloid and 25 mg of 
promethazine intravenously in the triage area and reported 
resolution of her nausea at the time of the initial interview by 
the EP. She described four similar episodes in the preceding 
year, for which she had been seen in the ED, treated 
symptomatically with intravenous fluids and promethazine 
and discharged with a diagnosis of gastroenteritis. She did 
note, however, that no other relatives or personal contacts 
were suffering from these symptoms.
Physical examination revealed vital signs consisting of an 
oral temperature of 36.7°C (98.0°F); blood pressure 137/106 
mm Hg; heart rate 114 beats/min; and a respiratory rate of 18 
breaths/min. She appeared in no apparent distress, was alert, 
awake, and oriented. Pertinent physical examination findings 
included the presence of normoactive bowel sounds and 
tenderness to palpation in the bilateral lower abdominal 
quadrants. She exhibited some voluntary guarding but had no 
rebound tenderness, percussive tenderness, or involuntary 
guarding. There were no remarkable cutaneous lesions 
visualized, nor were any abnormalities noted on inspection of 
the oropharynx. 
Mild abnormalities were detected on laboratory results, 
including: white blood cell count 10.38 K/µL; hemoglobin 
17.8 g/dL; hematocrit 53.4; platelet count 468 K/µL; blood 
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normal range and a negative urine pregnancy test. The 
patient’s elevated hemoglobin and hematocrit within this 
clinical context was interpreted to be evidence of 
hemoconcentration and dehydration. Only yeast was detected 
on urinalysis. 
Given the recurrent nature of her symptoms (four episodes 
within a year) and her abdominal exam findings, a computed 
tomography (CT) scan of the abdomen and pelvis with oral 
and intravenous contrast was obtained. The CT revealed 
dependant ascites in the abdominal and pelvic peritoneal 
cavities and discontinuous mural thickening in the proximal 
and middle small bowel suggestive of intestinal angioedema 
(Figures 1 and 2).
Upon review of the patient’s archived medical records, it 
was noted that she had previously been seen in the allergy 
clinic in 2004 with complaints of hand, foot and facial 
swelling. Biochemical testing performed at that time revealed 
a decreased C1 esterase inhibitor protein level of 5 mg/dL, and 
she was diagnosed with HAE and prescribed Danazol for 
prophylaxis against future attacks. However, the patient did 
not fill the prescription and was lost to follow-up. She had 
never previously experienced gastrointestinal symptoms 
related to her disorder prior to the past year and had not made 
the connection between her current symptoms and her 
diagnosis of HAE.
The patient’s allergist was called and notified of the 
patient’s presentation to the ED. He agreed that the totality 
of symptoms and clinical findings supported a diagnosis 
of an acute exacerbation of HAE, and an appointment was 
set within one week for further evaluation, treatment and 
definitive therapy. The patient reported that her symptoms had 
completely abated upon re-evaluation, and she was discharged 
home with a prescription for promethazine and instructions 
to consume clear liquids and advance her diet as tolerated for 
symptomatic control of her nausea.
DISCUSSION
HAE is a rare autosomal dominant disease first described 
by Sir William Osler in 1888.11 The disease is most commonly 
caused through a quantitative deficiency (type 1) or alternately 
due to a qualitative dysfunction (type 2) of the C1 esterase 
inhibitor protein in the plasma, which inhibits the action of 
vasodilators, such as kallikrein and bradykinin. Without 
inhibition from C1 esterase, bradykinin serves to increase 
vascular permeability resulting in angioedema that can occur 
at any mucosal or subcutaneous surface in the body.1
Although the patient in this case was suffering from a 
hereditary cause of her symptoms, the EP is more likely to 
encounter patients with angioedema due to ACE inhibitor use. 
However, angioedema from both etiologies presents similarly 
and share a common mechanism. ACE-inhibitors cause an 
excess of bradykinin by inhibiting its breakdown.12 Patients 
sensitive to increased levels of bradykinin will often only 
Figure	1.	Computed tomography revealing small bowel mural 
thickening and submucosal edema (arrows).
Figure	2.	More cephalad section of the same computed tomogra-
phy revealing areas of dependant ascites (arrows).
Table	1.	Clinical Features of intestinal Hereditary Angioedema 
and ACE-inhibitor associated angioedema.
•  Report of recent ACE-inhibitor use or prior diagnosis of HAE
•  Colicky abdominal pain, nausea and vomiting and delayed 
watery diarrhea
•  Vital signs and clinical findings suggestive of dehydration 
•  Concomitant angioedema of the face, pharynx, or extremities.
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complain of a persistent, dry nagging cough, which resolves 
upon discontinuation of the offending medication, but in rare 
circumstances, bradykinin excess precipitates angioedema. 
The clinical findings and treatment of intestinal angioedema 
are summarized in Tables 1 and 2.
Classically, HAE and ACE-inhibitor associated 
angioedema is located in the pharynx, extremities, or face. 
However, the bowel wall may be involved concomitantly in 
up to 75% of cases. Rarely, as we present in this case, 
angioedema of the bowel mucosa may be the only site of 
angioedema.2,13 The initial clinical presentation in patients with 
isolated gastrointestinal involvement may include colicky 
abdominal pain accompanied by nausea and vomiting that 
may easily be mistaken for appendicitis or biliary obstruction.2 
About a day into an acute attack, the patient may experience 
watery diarrhea secondary to extravasation of fluid into the 
intraluminal space.2 
Imaging with ultrasound or CT confirms the diagnosis of 
intestinal angioedema. Ultrasonography often reveals mucosal 
thickening and free peritoneal fluid in dependant areas of the 
abdomen, such as Morrison’s pouch.4 The sonographer may 
also detect a compressible but edematous bowel wall with 
increased intraluminal fluid and decreased motility.5 CT 
findings typically include massive edema of the small bowel 
or colon, prominent mesenteric vessels, thickened omentum, 
moderate ascites, and a normal appearance of the pericolic fat. 
Normal appearance of pericolic fat is useful for ruling out 
inflammatory changes seen in other diseases, such as 
appendicitis or diverticulitis.6,7 Other findings may include 
increased contrast enhancement of the small bowel and 
mucosa with visualization of additional layers of the small 
bowel wall.8 Such findings are usually transient and will 
resolve following an acute episode of HAE or ACE-inhibitor 
associated angioedema.8,10 The appendix and gallbladder are 
usually well visualized, which may serve to effectively rule 
out some surgical etiologies if they are not involved.6 The 
differential diagnosis suggested by the findings on a 
characteristic CT for angioedema involving the bowel can be 
rather narrow and include ischemia and intramural bleeding 
secondary to coagulopathy or trauma.2
ACE-inhibitor induced angioedema is a clinical diagnosis, 
but use of diagnostic tests to determine the cause of 
angioedema in the ED is limited. If HAE is suspected, the 
diagnosis can be confirmed with a C1 esterase inhibitor level, 
although this may not practical or available in the ED setting. 
If performed, the normal limits of C1 esterase typically range 
from 21-39 mg/dL. A low C1 esterase inhibitor level is 
consistent with a diagnosis of HAE. In addition reduced levels 
of C2 and C4, which are substrates of the C1 esterase enzyme, 
further enhance specificity.1,2,3.
The management of this rare disorder in the ED remains 
largely undefined. Intestinal angioedema may be a particular 
challenge due to its rarity and the broad differential associated 
with its presentation. Unrecognized and untreated cases 
of angioedema exacerbations as a whole carry a mortality 
rate of 30-56%.5,13 Airway patency should be a priority in 
cases involving the oropharyngeal structures. When acute 
abdominal symptoms are present, surgical consultation may 
be prudent or required if there are doubts about the etiology 
of the clinical and radiologic findings, particularly when the 
patient is experiencing hemodynamic instability.10 In terms 
of immediate management, administration of C1 inhibitor 
concentrate and fresh frozen plasma have been reported to be 
effective in rapid reversal of some attacks.13-15 Cases related 
specifically to ACE-inhibitor associated angioedema are 
primarily treated through recognition and discontinuation 
Table	2. Diagnosis and treatment of intestinal angioedema. 
Diagnosis Hereditary angioedema ACE-inhibitor associated angioedema
Biochemical tests •  C1 esterase less than 21mg/dL
•  Reduced C2 and C4 levels
•  None indicated
Ultrasound  •  Bowel mucosal thickening
•  Ascites
Computed tomography •  Massive small bowel or colonic edema
•  Prominent mesenteric vessels
•  Thickened omentum
•  Moderate ascites
•  Normal pericolic fat
Treatment •  Maintain airway patency 
•  Antihistamines
•  Steroids
•  IM Epinephrine 1:1000 
•  C1 inhibitor concentrate, fresh frozen plasma 
and/or DX-88 infusion
•  Maintain airway patency 
•  Antihistamines
•  Steroids
•  IM Epinephrine 1:1000
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of the offending agent. Antihistamines, steroids and 
intramuscular epinephrine 1:1000 may be used as adjunct 
therapies in cases where edema threatens airway patency. 
However, their efficacy has not been tested in clinical trials 
and is based on anecdotal reports. Recently, infusion of 
DX-88, a synthetic, potent inhibitor of kallikrein, has been 
successfully applied to accelerate resolution of attacks.9 
Long term management for either etiology should include 
permanent discontinuation of ACE-inhibitors and close 
referral to an allergy and immunology specialist. For cases 
of HAE, androgen derivatives have been successful in terms 
of prophylaxis.13,15 Danazol is perhaps the most commonly 
prescribed agent, and tranexamic acid has been reported to be 
effective in terms of symptomatic treatment of swelling in up 
to 70% of patients.13,15 
CONCLUSION
Angioedema secondary to HAE or ACE-inhibitor use 
is classically associated with facial and tongue swelling. 
However, intestinal angioedema commonly occurs in 
combination with facial involvement and rarely may occur in 
isolation. EPs must remain mindful of this entity, particularly 
in patients on ACE inhibitors or with a history of HAE 
presenting with acute abdominal pain, vomiting, or diarrhea. 
Early diagnosis may prevent morbidity from unnecessary 
exploratory surgery. Treatment of ACE-inhibitor-associated 
angioedema consists mainly of cessation of the offending 
agent; the management of HAE is much more poorly defined 
and should at minimum consist of supportive care and 
consultation with an allergy and immunology specialist.
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